Occidental volunteer Fire Chief Ron Lunardi nebulizes compounded glutathione at one of our firefighter wellness clinics / 2021

On July 31-Aug 1, the California Board of Pharmacy may vote to eliminate firefighters’ best detox tool –

unless we stop them.

(SIGN THE PETITION)

A quick summary:

Integrative doctors worldwide use sterile-compounded glutathione to treat conditions from asthma to cancer.

Critically for firefighters, glutathione is also an environmental medicine doctor’s primary treatment to reduce chemical exposure and prevent cancer.

Since 2021, we’ve featured glutathione in all our wellness programming, from integrative wellness and lung detoxification clinics to the ground-breaking firefighter detoxification research pilot we co-sponsor.

The results from the first two rounds of the research pilot are promising (details below) and we plan to expand our research – if we can access the medication.

No more glutathione?

After years of quietly stripping away patient access, the California Board of Pharmacy is poised to ban sterile compounding pharmacists from dispensing an entire class of medications – including glutathione – despite offering no legitimate legal or scientific justification.

If they succeed, California will become the only state where these medications are no longer available.

To learn more

(or keep scrolling)

What is glutathione?

Sometimes called the “mother of all antioxidants,” glutathione is a naturally occurring compound produced in the liver and present in virtually every cell in the human body.

When administered as a sterile-compounded medication through a nebulizer or IV, glutathione effectively supercharges the body’s detoxification pathways, allowing for rapid and significant reduction in a patient’s overall chemical burden.

What can glutathione do for firefighters?

“So far, ten of our members, including me, and many more to come, have seen how have seen how this detoxification program has greatly reduced the amount of cancer-causing toxins in our bodies.”

Sonoma Valley Fire Chief Steve Akre, a member of the executive board of the California Fire Chiefs Association, testifies at a public hearing on sterile compounding June 18, 2024.

We know from years of experience that compounded glutathione can help firefighters reduce their chemical burdens, heal chronic coughs, and reverse liver disease, but we’re determined to find out just how effective it can be.

In partnership with the nonprofit Integrative Healers Action Network and Wild Oak Medicine, the Volunteer Fire Foundation has now administrated two rounds of a groundbreaking firefighter detoxification pilot study based in Sonoma County, California. So far, the program has been funded by local fire agencies, which sponsor their firefighters’ participation.

Round 1 (2023):

The first round of the study consisted of ten firefighters (a mix of full-time and volunteers) from three local agencies.

Participants completed 16 weeks of doctor-led, integrative treatment, which included intravenous, nebulized, and liposomal glutathione as well as sauna, massage, and supportive supplements.

They were each tested three times – before treatment, halfway through, and immediately after completion – for petrochemicals, heavy metals, mold toxins, environmental chemicals, and PFAS chemicals.

Key takeaways

  • Before treatment, each participant had an average of over four toxins in the 95th percentile. At the end of treatment, that number dropped to one toxin in the 95th percentile per participant (a 72.5% decrease)

  • Glyphosate was among the top three most prevalent toxins, with many participants showing levels 2-3 times the 95th percentile. By the end of treatment, glyphosate levels decreased 93% 

  • Participants’ PFAS levels shifted during the course of treatment, indicating that it may be possible to mobilize these chemicals – and if we can mobilize them, we may be able to reduce or even eliminate them

Early results from the second round are even more compelling

Round 2 (2024)

The second round of the detoxification pilot consisted of eleven participants (a mix of paid and volunteers) from two departments.

They were tested for the same chemicals and underwent the same treatment modalities as the participants in Round 1 but this time the study’s medical director reduced the treatment window from 16 to 12 weeks.

Final test results from all Round 2 participants should arrive by mid-July 2024, but the first three sets of data are extremely promising:

Key takeaways

  • Participant 1 started with zero toxins in the 95th percentile and five in the 75th. After treatment, all toxin levels were in the normal range

  • Participant 2 started with four toxins in the 95th percentile and eight in the 75th. After treatment, he had zero toxins in the 95th percentile and six in the 75th. Additionally, his chronic liver disease was no longer detectable

  • Participant 3 started with 16 toxins in the 95th percentile and 17 toxins in the 75th. After treatment, he had two toxins in the 95th – an 87.5% decrease – and 11 toxins in the 75th. As with Participant 2, his chronic liver disease was no longer detectable

Participant 3 is a striking case study.

A firefighter for two decades, he has been diagnosed with bladder cancertwice.

In Test 1 (pre-treatment), nine of his sixteen toxins that were in the 95th percentile were PFAS chemicals. One of them was especially concerning:

Before treatment, Participant 3’s perfluoro-n-(1,2-13C2) hexanoic acid level was fourteen times the 95th percentile. After treatment, it dropped from 4.585 to 0.172 –

a 96.25% reduction.

Even more incredible:

Every toxin in his system decreased from Test 1 to Test 2 – and again from Test 2 to Test 3.

TEST 1

  • 16 toxins in 95th percentile (red)

  • 17 toxins in 75th percentile (yellow)

TEST 3

  • 2 toxins in 95th percentile (red)

  • 11 toxins in 75th percentile (yellow)

** The light blue markers indicate Participant’s Test 2 results, which were submitted at the halfway point of the program.

I don’t care if it’s a small sample size. My labs clearly show that glutathione works. Every firefighter should speak up against the California Board of Pharmacy right now because every firefighter deserves access to this medication. If I’d discovered glutathione sooner, maybe I would’ve never gotten cancer.
— Pilot Round 2, Participant 3

If the California Board of Pharmacy eliminates access to sterile-compounded glutathione, there is no relacement.

What’s motivating the California BOP?

We don’t know.

We’ve spoken with physicians, lawyers, pharmacists, and pharmacy experts across the United States and no one seems to understand what’s motivating the BOP’s extreme stance – but it’s not just glutathione they’re after.

Over the past few years, the California Board of Pharmacy has waged war against sterile compounding pharmacy itself, filing eight lawsuits against reputable sterile compounding pharmacies.

The lawsuits challenge pharmacists’ right to dispense FDA Category 1 substances (not to be confused with Schedule I controlled substances), including glutathione, methylcobalamin (vitamin B12), various peptides and other substances.

The Board has lost all eight lawsuits but that hasn’t stopped its executive staff from seeking to eliminate our access to these lifesaving and life-changing medications.

The FDA has deemed glutathione to be safe. There is no scientific or medical reason why we shouldn’t have access.

We need your help to #stopthebop.

Here’s what you can do:

  1. Sign and share this petition.

    Bonus points if you specify that you’re a firefighter. (If you’re a member of a local, share that too.)

  2. Learn more.

    Explore the resources below or email VFF executive director Jacqui Jorgeson at jacqui@volunteerfire.org.

  3. Spread the word.

    Tell your firefighter brothers and sisters. Tell your chief. Tell your union reps. Tell everyone because the impact of this vote extends far beyond the fire service.